Hi, RB.
Any debate is somewhat pointless without accurate and comprehensive statistics. The figures quoted in the referenced article seem to have originated with the Government website: https://www.canada.ca/en/health-can...nsed-producers/market-data/supply-demand.html
which should be accurate, but are insufficiently detailed. I assume that cannabis in all its forms would be priced by grade - perceived quality as well as purity - but I can only find a generic price/gram. If there isn't a grading system, then there is a market failure which needs fixing.
RotoGrown product is intended to be top quality and uncontaminated; it should fetch premium prices.
Solving an inventory glut (if there is one and it continues) will be complicated. Production controls, cross-border sales, market forces, political dynamics and egos, roadside drug testing...How that all plays out seems unpredictable. And then there is the possibility that pharmaceutical-grade CBD will mostly be synthetically produced. Apart from all that, RotoGro may, as you say, be somewhat insulated from this issue.
RGI Price at posting:
16.0¢ Sentiment: None Disclosure: Held
